EMAIL THIS PAGE TO A FRIEND

Metabolism: clinical and experimental

Hypoglycemic effects of a beta-agonist, Ro 16-8714, in streptozotocin-diabetic rats: decreased hepatic glucose production and increased glucose utilization in oxidative muscles.


PMID 1346545

Abstract

Streptozotocin (STZ)-induced diabetic rats are glycosuric, hyperglycemic, hyperketonemic, overproduce glucose, and have a decreased glucose utilization in oxidative muscles. Treatment with a beta-agonist, Ro 16-8714, decreases the glycosuria, hyperglycemia, hyperketonemia, and hepatic glucose production. Tissue glucose utilization was unchanged, except in oxidative muscles, where it was increased.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

A72405
2-Amino-1-phenylethanol, 98%
C8H11NO